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Abstract
Previous studies of depression after stroke have reported widely variable findings, possibly due to differences
between studies in patient characteristics and methods for the assessment of depression, small sample sizes, and
the failure to examine stroke-free reference groups to determine the base rate of depression in the general
population. In an effort to address certain of those methodologic issues and further investigate the frequency
and clinical determinants of depression after stroke, we administered the Structured Interview Guide for the
Hamilton Depression Rating Scale (SIGH–D) and neurological, neuropsychological, and functional assessments
to 421 patients (age 5 71.5 6 8.0 years) 3 months after ischemic stroke and 249 stroke-free control subjects
(age 5 70.8 6 6.7 years). We required a SIGH–D total score . 11 for the identification of depression. We found
that depression was less frequent (470421 patients, or 11.2%, and 130249 control subjects, or 5.2%), less severe,
and less persistent in our stroke cohort than previously reported, possibly due to the underrepresentation of patients
with a premorbid history of affective illness. Depression was associated with more severe stroke, particularly in
vascular territories that supply limbic structures; dementia; and female sex. SIGH–D item analyses suggested that
a reliance on nonsomatic rather than somatic symptoms would result in the most accurate diagnoses of depression
after ischemic stroke. (JINS, 2003, 9, 429–439.)
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INTRODUCTION
Given that ischemic stroke is associated with a variety of
adverse outcomes, including dementia (Desmond et al.,
2000), dependent living (Pohjasvaara et al., 1998a), and
death (Sarti et al., 2000), it is reasonable to presume that
many stroke patients will experience significant depres-
sion. Although a number of prior studies have suggested
that depression is a common consequence of stroke (Kotila
et al., 1998; Pohjasvaara et al., 1998b; Robinson et al., 1983),
that it is associated with specific lesion locations (Robin-
son et al., 1983, 1984; Starkstein et al., 1987, 1989), and
that it may have an adverse impact on cognitive function
(Bolla-Wilson et al., 1989), physical recovery (Parikh et al.,
1990), and survival (Morris et al., 1993), the results of stud-
ies of the frequency, determinants, and consequences of
post-stroke depression have been remarkably variable when
considered as a group (Gordon & Hibbard, 1997). Certain
methodologic features may have contributed to that vari-
ability, including differences between studies in patient char-
acteristics and methods for the assessment of depression,
small sample sizes, and the failure to examine stroke-free
reference groups to determine the base rate of depression in
the general population.
As a component of a prospective study of stroke and
dementia (Desmond et al., 2000), we administered a
standardized depression assessment to a large cohort of
well-characterized ischemic stroke patients as well as a
stroke-free age-matched reference group. Our goal in this
subproject was to answer five specific questions: (1) What
is the frequency of depression after ischemic stroke? (2) How
do older subjects with and without stroke differ with regard
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to the frequency of the conventionally accepted symptoms
of depression? (3) What are the clinical determinants of
depression among ischemic stroke patients? (4) Is depres-
sion associated with dementia after stroke? and (5) How do
stroke patients with and without dementia differ with re-
gard to the frequency of the conventionally accepted symp-
toms of depression? We hypothesized that (1) stroke patients
would meet criteria for depression more frequently than
control subjects but less frequently than previously re-
ported; (2) stroke patients would report depressed mood as
well as a variety of somatic symptoms more frequently than
control subjects; (3) depression among stroke patients would
be associated with the severity of neurologic impairment
but not lesion location; and (4) stroke patients with demen-
tia would meet criteria for depression more frequently than
nondemented patients, primarily due to a higher frequency




We recruited 585 subjects among patients consecutively ad-
mitted to Columbia-Presbyterian Medical Center for ische-
mic stroke. We recruited 297 of those patients from 1988 to
1990 and the remaining 288 patients from 1994 to 1997,
those two recruitment phases corresponding to two funding
cycles. Eligibility requirements included an age 60 years or
older and a diagnosis of ischemic stroke within the previ-
ous 30 days confirmed by brain imaging (relevant infarct or
normal). When brain imaging was normal, the diagnosis of
ischemic stroke was based on the patient’s clinical history
and the results of the neurologic examination (e.g., a pre-
sentation that includes the acute onset of a left hemiparesis
that persists for at least 24 hr). Patients were permitted to be
of either sex and any race or ethnicity and patients with a
history of prior stroke or prior psychiatric illness were eli-
gible for inclusion.
Patients were excluded when certain clinical features
precluded a reliable assessment of cognitive function, in-
cluding a Boston Diagnostic Aphasia Examination (Good-
glass & Kaplan, 1983) severity rating under 3 (lower scores
represent greater severities of aphasia), impairment of con-
sciousness persisting beyond the permitted 30-day post-
stroke enrollment period, or a primary language other than
English or Spanish. Additional exclusion criteria included
the presence of a concomitant neurologic disorder poten-
tially affecting cognitive function (e.g., Parkinson’s dis-
ease) or a severe comorbid medical illness (e.g., terminal
cancer) that would preclude follow-up throughout the five-
year duration of this prospective study. Patients were not
excluded if a premorbid history of functional impairment
suggested that they might have concomitant Alzheimer’s
disease because our larger study was designed to investi-
gate both cerebrovascular disease and Alzheimer’s disease
as the two most frequent causes of dementia in the general
population. Among patients who were otherwise eligible
for inclusion, the most common reasons for exclusion from
our study were the presence of neurologic deficits that
were too severe to permit reliable and valid assessments
(approximately 33% of those who were excluded), refusal
of enrollment by the patient and0or the patient’s family
(approximately 33% of those who were excluded), and the
presence of a severe comorbid medical illness that would
preclude follow-up throughout the 5-year duration of this
study (approximately 15% of those who were excluded).
We also recruited a control cohort of 249 subjects (age 5
70.8 6 6.7 years; education 5 12.3 6 4.6 years) who were
free of any history of stroke or evidence of stroke in neuro-
logic examination. Similar to the approach that we took to
the recruitment of our stroke cohort, control subjects were
not excluded if a premorbid history of functional impair-
ment suggested that they might have Alzheimer’s disease.
Our focus upon stroke as the primary distinguishing feature
between the stroke and control cohorts thus permits the
direct assessment of that variable as a risk factor for depres-
sion, independent of other potentially confounding vari-
ables. Regarding additional demographic characteristics in
our control cohort, 65.9% of the subjects were women, and
32.5% were Black, 14.9% were Hispanic, and 52.6% were
White. The majority of the control cohort was randomly
selected from the surrounding community based on a Medi-
care list, while the remaining subjects were spouses of stroke
patients also enrolled in our study, who we recognize were
likely to be at increased risk of depression themselves, or
neighborhood volunteers who came to our attention due to
advertisements or referrals by friends. As a group, control
subjects were matched to the stroke cohort by age.
This study was approved by the Institutional Review Board
of Columbia-Presbyterian Medical Center and all subjects
provided informed consent.
General Examination Procedures
We performed our initial assessments 7 to 10 days after
stroke. All patients were administered the Mini-Mental State
Examination (MMSE; Folstein et al., 1975), a popular men-
tal status screening test, and the Barthel Index (Mahoney &
Barthel, 1965), which taps the physical aspects of activities
of daily living. Neurologists specializing in stroke admin-
istered a structured neurologic examination and docu-
mented any history of stroke, transient ischemic attack, or
exposure to risk factors for cerebrovascular disease based
on review of medical records and a structured interview
administered to all patients and knowledgeable informants.
Consistent cigarette use (i.e., at least 1 cigarette per day for
at least 1 year) and consistent alcohol use (i.e., at least 1
serving of beer, wine, or hard liquor per week for at least 6
months) were also documented. A comprehensive medical
history was recorded and any past psychiatric illnesses re-
ported by the patient or a reliable informant or recorded in
the patient’s medical records were noted. Patients were also
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rated on the Stroke Data Bank Stroke Severity Scale (Foulkes
et al., 1988). As part of routine clinical care, most of the
patients recruited as part of our first cohort underwent a CT
scan while most of the patients recruited as part of our
second cohort underwent an MRI. In virtually all cases,
brain imaging was performed on the day of admission, with
follow-up scans typically performed when the initial scan
did not demonstrate a relevant lesion. Based upon the re-
view of clinical features and brain imaging studies, patients
were classified by infarct location and stroke syndrome using
a modification of the methods of the Stroke Data Bank.
Characterization of the stroke syndrome was based upon
the severity of the patient’s neurologic deficits (e.g., major
vs. minor) and the location of the infarction (e.g., left vs.
right hemisphere).
Three months after stroke, all patients were administered
the Structured Interview Guide for the Hamilton Depres-
sion Rating Scale (SIGH–D; Williams, 1988) and readmin-
istered the MMSE, the Barthel Index, the neurologic
examination, and the Stroke Severity Scale. A comprehen-
sive battery of neuropsychological tests developed for use
in epidemiologic studies of dementia (Stern et al., 1992)
was also given at that time. That battery was administered
in either English or Spanish, based upon the language spo-
ken in the subject’s home, and it included measures of ver-
bal and nonverbal memory (the Selective Reminding Test
and a multiple-choice recognition version of the Benton
Visual Retention Test), orientation (the Mini-Mental State
Examination orientation subtest), language (a 15-item ver-
sion of the Boston Naming Test, letter and category fluency
tests, and selected items drawn from the repetition and com-
plex ideation subtests of the Boston Diagnostic Aphasia
Examination), visuospatial function (the Rosen Drawing Test
and a multiple-choice matching version of the Benton Vi-
sual Retention Test), verbal and nonverbal abstract reason-
ing skills (the Similarities subtest of the Wechsler Adult
Intelligence Scale–Revised and the Identities and Oddities
subtest of the Mattis Dementia Rating Scale), and attention
(cancellation tasks using shapes and letters as targets).
Knowledgeable informants were administered the Blessed
Functional Activity Scale (BFAS; Blessed et al., 1968), which
taps the cognitive aspects of activities of daily living. De-
mentia was diagnosed based on criteria modified from the
Diagnostic and Statistical Manual of Mental Disorders, Third
Edition, Revised (DSM–III–R; American Psychiatric Asso-
ciation, 1987) and consistent with criteria later proposed by
the International Workshop of the National Institute of
Neurological Disorders and Stroke–Association Internatio-
nale pour la Recherche et l’Enseignement en Neurosci-
ences (Román et al., 1993). Essentially, we required deficits
in memory and two or more additional cognitive domains
as determined in the neuropsychological evaluation as well
as functional impairment not solely related to physical dis-
ability documented with the BFAS.
All available and willing patients were then seen for an-
nual follow-up examinations during which all of the above
assessments were repeated. Virtually all patients were hos-
pitalized when they were assessed 7 to 10 days after stroke
and virtually all patients were seen in our outpatient clinic
when they were assessed three months and annually after
stroke. Most of the 3-month post-stroke assessments were
performed in the morning, although we did not require that
they be performed at a specific time of day as part of our
protocol.
Assessment of Depression
As noted above, we used the SIGH–D for the identification
of depression. We selected the SIGH–D because the Ham-
ilton Depression Rating Scale (HDRS; Hamilton, 1960,
1967) has been one of the most popular scales in studies of
post-stroke depression, it is administered in a structured
format, and it is not unduly demanding for use with stroke
patients. In the SIGH–D, questions are posed to patients
with regard to the presence or absence of the convention-
ally accepted symptoms of depression during the preceding
week and follow-up questions are provided to elicit infor-
mation that is directly relevant to scoring. The first ques-
tion is, “What has your mood been like this past week?”,
for example, and it is followed by additional inquiries in-
cluding, “Have you been feeling down or depressed?” and
“Have you been crying at all?” Items are scored according
to the frequency and intensity of depressive symptoms. Scor-
ing options for that first question are zero points for the
absence of depression, 1 point for depression that is indi-
cated only on questioning, 2 points for depression that is
spontaneously reported verbally, 3 points for depression
that is communicated nonverbally (e.g., facial expression,
tendency to weep), and 4 points for depression that is es-
sentially the only focus of spontaneous verbal and nonver-
bal communication. All items were rated without assumptions
regarding causation.
A cutoff score of 16 has been used in nonstroke samples
based on the original version of the HDRS, but stroke stud-
ies have typically used lower cut-off scores (Andersen et al.,
1994a). Trichotomous cut-off scores of over 24 for severe
depression, 18 to 24 for moderate depression, 7 to 17 for
mild depression, and zero to 6 for no depression have also
been proposed (Endicott et al., 1981). Since no consensus
exists on the optimal cut-off score to use for the identifica-
tion of depression in a stroke sample, we used an intermedi-
ate cut-off of a score over 11 for that purpose in our study.
Given that concerns have been expressed regarding the prob-
lematic influence of somatic scale items on the diagnosis of
depression after stroke (Stein et al., 1996), we also per-
formed secondary analyses in which we additionally re-
quired a score over 1 on the first SIGH–D item, which
represents the spontaneous acknowledgment of depressed
mood. In most cases, the SIGH–D was administered by
research assistants, who were trained and supervised by a
clinical psychologist (R.H.R.) on a continuing basis. When
patients were considered to be unreliable, their responses
on the SIGH–D were corroborated with reliable infor-
mants, when available. Neurologists were blind to the re-
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sults of the depression assessments when they performed
their clinical examinations and reviewed brain imaging
studies.
Studies of the reliability and validity of the SIGH–D and
the HDRS in stroke samples are worthy of note. In our own
work (reviewed in Desmond, 2000), three trained research
assistants and one clinical psychologist administered the
SIGH-D to 32 elderly ischemic stroke patients and 20 el-
derly stroke-free control subjects. Intraclass correlation co-
efficients were excellent for the 17-item total score (i.e., .96
for all raters and .97 for the three research assistants) and
all but 2 of the 17 individual items (i.e., observer ratings of
psychomotor retardation and agitation), including items re-
lated to depressed mood and anhedonia (i.e., .86 and .87,
respectively). The results were comparable when data col-
lected from the stroke and control groups were examined
separately. Malec et al. (1990) reported an interrater relia-
bility of .77 for the HDRS based on a Pearson correlation,
with the second assessment administered within 11 days of
the first assessment. Regarding the validity of the HDRS in
stroke samples, Pearson correlations of .77, .74, and .70
have been reported for the association between HDRS total
score and scores on the Geriatric Depression Scale, the Cen-
ter for Epidemiologic Studies Depression Scale, and the
Zung Self-Rating Depression Scale, respectively, in stroke
patients (Agrell & Dehlin, 1989). Other studies of patients
with stroke have found that the HDRS total score increases
with the severity of depression (Ng et al., 1995) and de-
creases in association with the effective treatment of depres-
sion (Andersen et al., 1994b).
Statistical Analyses
To determine whether any selection bias might have re-
sulted from our failure to examine a subset of patients 3
months after stroke, chi-square analyses were performed to
compare the patients who were not examined to those pa-
tients who were examined with regard to the location, se-
verity, and clinical manifestations of the presenting stroke;
vascular risk factors; psychiatric history; and demographic
and social variables. We then performed a logistic regres-
sion analysis to determine whether any of the variables found
to be related to the failure to be examined 3 months after
stroke in the univariate analyses ( p , .10) would be inde-
pendently related to the failure to be examined.
We next performed a logistic regression analysis to char-
acterize the risk of depression in the stroke versus the con-
trol cohort. To investigate the clinical determinants of
depression, we performed chi-square analyses to compare
the pooled group of patients who met criteria for depression
to those who did not meet criteria for depression with re-
gard to the clinical variables summarized above. We then
performed a logistic regression analysis to determine whether
any of the variables found to be relevant in the univariate
analyses ( p , .10) would be independently related to de-
pression status. To investigate the SIGH–D items that best
distinguished stroke patients from control subjects and de-
mented patients from nondemented patients, we performed
chi-square analyses to compare each of those pairs of groups
with regard to the frequency of positive responses to each
SIGH–D item. We then performed logistic regression analy-
ses to determine whether any of the SIGH–D items found to
be related to stroke or dementia status in the univariate
analyses ( p , .10) would be independently related to stroke
or dementia status.
All logistic regression analyses were based on a back-
ward stepwise variable removal method, with the criterion
for variable removal set at p $ .10. We selected that rela-
tively liberal criterion rather than p , .05 because we sought
to identify even weakly related variables, particularly those
recognized in our primary analysis of the clinical determi-
nants of depression that might be amenable to intervention.
RESULTS
Clinical Characteristics of Patients Lost
to Follow-Up
Of the 585 patients who met our eligibility criteria and
were initially enrolled in our study, 421 patients (72.0%;
age 5 71.5 6 8.0 years) were examined 3 months after
ischemic stroke. Of the 164 patients who were not exam-
ined, 26 patients had died, 40 patients were medically ill
or too severely impaired neurologically to be assessed,
and 98 patients refused follow-up, had moved, or had been
lost to follow-up. Thus, of the 519 patients who could
potentially have been examined, 421 (81.1%) were actu-
ally examined. Patients who were not examined 3 months
after stroke were significantly more impaired than patients
who were examined on the MMSE (20.5 6 6.3 vs. 23.4 6
5.1), the Barthel Index (58.3 6 33.1 vs. 70.9 6 27.1), and
the Stroke Severity Scale (7.6 6 3.0 vs. 6.6 6 3.1) admin-
istered 7 to 10 days after stroke based on t tests. Chi-
square analyses suggested that the failure to be examined
3 months after stroke was associated with the stroke syn-
drome, the location of the index stroke, congestive heart
failure, atrial fibrillation, and age. Given that the stroke
syndrome variable contained numerous response options,
we recoded it into a dichotomous variable (i.e., major dom-
inant and major nondominant syndromes versus all other
syndromes) and found that a major hemispheral stroke
syndrome, representing more severe neurologic impair-
ment resulting from an infarction involving the left or right
cerebral hemisphere, was associated with the failure to be
examined three months after stroke. Logistic regression
determined that the failure to be examined was indepen-
dently associated with a major hemispheral stroke syn-
drome (odds ratio, OR: 1.67; 95% confidence interval, CI:
1.07–2.61), congestive heart failure (OR: 1.66; CI: .98–
2.83), and age 80 or older (OR: 2.52; CI: 1.54– 4.13) and
70 to 79 (OR: 1.61; CI: 1.04–2.47) versus 60 to 69.
Frequency and Severity of Depression After
Ischemic Stroke
Three-month post-stroke SIGH–D total scores stratified by
the spontaneous acknowledgment of depressed mood (i.e.,
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a SIGH–D first item score . 1) are presented in Figure 1.
Although the mean SIGH–D total scores of both the stroke
and control cohorts were relatively low, clinically similar,
and far below our cut-off for the identification of depres-
sion, the total score of the stroke cohort was significantly
higher than the total score of the control cohort by t test
(4.9 6 4.8 vs. 3.5 6 3.9, p , .001). Forty-seven of the 421
stroke patients (11.2%) and 13 of the 249 control subjects
(5.2%) received a SIGH–D total score over 11 3 months
after stroke, yielding an odds ratio of 2.52 (CI: 1.33– 4.80)
for depression associated with stroke, adjusting for female
sex (OR: 2.17; CI: 1.20–3.92). Thirty-one of the 421 pa-
tients (7.4%) and 10 of the 249 control subjects (4.0%)
received a SIGH–D total score over 11 and spontaneously
acknowledged depressed mood, yielding an odds ratio of
2.07 (CI: 0.99– 4.35), adjusting for female sex (OR: 2.22;
CI: 1.08– 4.56).
Among the 47 patients who met criteria for depres-
sion 3 months after stroke, 4 patients (8.5%) were taking
anti-depressant medications, 6 patients (12.8%) were tak-
ing anxiolytic medications, and 3 patients (6.4%) were tak-
ing anti-psychotic medications. Among the 374 patients who
did not meet criteria for depression three months after stroke,
21 patients (5.6%) were taking anti-depressant medica-
tions, 15 patients (4.0%) were taking anxiolytic medica-
tions, and 3 patients (0.8%) were taking anti-psychotic
medications.
Clinical Determinants of Depression After
Ischemic Stroke
Within the stroke cohort, patients meeting criteria for de-
pression 3 months after stroke were significantly more im-
paired than nondepressed patients on the MMSE (22.3 6
5.9 vs. 24.9 6 4.6), the Barthel Index (73.9 6 31.9 vs.
87.0 6 21.4), and the Stroke Severity Scale (6.8 6 3.1 vs.
5.1 6 3.2) administered at that time based on t tests. Demo-
graphic and social characteristics stratified by depression
status are shown in Table 1, vascular risk factors and psy-
chiatric history stratified by depression status are shown in
Table 2, and stroke characteristics stratified by depression
status are shown in Table 3. Chi-square analyses suggested
that depression was associated with dementia, a major hemi-
spheral stroke syndrome, infarcts in the pooled anterior ce-
Fig. 1. Structured Interview Guide for the Hamilton Depression Rating Scale total score stratified by the spontaneous
acknowledgment of depressed mood in the stroke cohort.
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rebral artery (ACA) and posterior cerebral artery (PCA)
territories versus infarcts in other vascular territories, a Bar-
thel Index score of 80 or less, and sex. Logistic regression
determined that depression 3 months after stroke was inde-
pendently associated with dementia (OR: 3.18; CI: 1.65–
6.14), a major hemispheral stroke syndrome (OR: 1.68; CI:
.80–3.53), infarcts in the pooled ACA and PCA territories
versus infarcts in other vascular territories (OR: 1.64; CI:
.78–3.48), and female sex (OR: 1.67; CI: .86–3.23). A
further logistic regression analysis determined that depres-
sion with the spontaneous acknowledgement of depressed
mood was independently associated with dementia (OR:
2.60; CI: 1.16–5.82), a major hemispheral stroke syndrome
(OR: 2.34; CI: .99–5.50), infarcts in the pooled ACA and
PCA territories versus infarcts in other vascular territories
(OR: 2.50; CI: 1.07–5.84), angina (OR: 1.78; CI: .77–
4.09), and female sex (OR: 1.70; CI: .75–3.84).
Depression During Long-Term Follow-Up
In our stroke cohort, 336 of the 421 patients (79.8%) had at
least 1 follow-up examination. Specifically, 85 of the 421
patients (20.2%) had no follow-up examinations, 100 pa-
tients (23.7%) had 1 follow-up examination, 80 patients
(19.0%) had 2 follow-up examinations, 68 patients (16.2%)
had 3 follow-up examinations, and 88 patients (20.9%) had
4 or more follow-up examinations. Regarding the clinical
course of the 47 patients who met criteria for depression 3
months after stroke, 37 of those 47 patients (78.7%) were
evaluated at least once following that baseline assessment.
The mean change in SIGH–D total score between that base-
line assessment and each patient’s final assessment was a
decrease of 6.62 6 5.85 points. The magnitude of change
ranged from a decrease of 18 points to an increase of 4
points. Thirty of the 37 patients (81.1%) who met criteria
for depression in that baseline assessment exhibited a de-
crease of 1 or more points and 13 of those 37 patients (35.1%)
exhibited a decrease of 10 or more points. Twenty of those
37 patients (54.0%) never again received a SIGH–D total






(n 5 374) p
Age
$ 80 years 7 (14.9) 62 (16.6) .643
70–79 years 20 (42.6) 133 (35.6)
60– 69 years 20 (42.6) 179 (47.9)
Education
0–8 years 17 (36.2) 136 (36.4) .872
9–12 years 20 (42.6) 147 (39.3)
$ 13 years 10 (21.3) 91 (24.3)
Ethnicity0race
Black 15 (32.6) 146 (39.8) .173
Hispanic 21 (45.7) 117 (31.9)
White 10 (21.7) 104 (28.3)
Sex (female) 31 (66.0) 188 (50.3) .042
Predominant language (English) 26 (55.3) 235 (63.0) .306
Occupation (unskilled) 24 (51.1) 204 (54.8) .624
Handedness (right) 45 (97.8) 345 (93.0) .209
Residence (northern Manhattan) 22 (46.8) 176 (47.1) .974
Living alone at stroke onset 16 (34.0) 128 (34.5) .950
Note. Figures are frequencies and within-group percentages. Significance
levels are based on chi-square analyses. Some within-group percentages
are based on an incomplete sample due to small amounts of missing data.







(n 5 374) p
Hypertension 32 (68.1) 274 (73.5) .435
Diabetes mellitus 18 (38.3) 126 (33.7) .530
Myocardial infarction 8 (17.0) 64 (17.2) .975
Angina 13 (27.7) 82 (22.2) .397
Atrial fibrillation 5 (10.6) 49 (13.2) .625
Congestive heart failure 6 (12.8) 38 (10.2) .595
Hypercholesterolemia 12 (25.5) 85 (23.0) .703
Consistent cigarette use 25 (53.2) 219 (59.2) .432
Consistent alcohol use 22 (46.8) 186 (50.3) .655
Prior stroke 9 (19.6) 93 (25.0) .418
Prior transient ischemic attack 5 (10.9) 63 (17.1) .281
History of psychiatric illness 4 (8.5) 20 (5.4) .381
Note. Figures are frequencies and within-group percentages. Significance
levels are based on chi-square analyses. Some within-group percentages
are based on an incomplete sample due to small amounts of missing data.






(n 5 374) p
Stroke syndrome
Major dominant hemispheral 7 (14.9) 27 (7.2) .095
Major nondominant hemispheral 7 (14.9) 31 (8.3)
Minor dominant hemispheral 3 (6.4) 54 (14.4)
Minor nondominant hemispheral 5 (10.6) 53 (14.2)
Lacunar0deep hemispheral 19 (40.4) 129 (34.5)
Brainstem0cerebellar 6 (12.8) 80 (21.4)
Stroke location
Left hemisphere 17 (36.2) 124 (33.2) .598
Right hemisphere 19 (40.4) 135 (36.2)
Brainstem0cerebellum 11 (23.4) 114 (30.6)
Frontal location of presenting stroke 10 (21.3) 81 (21.7) .952
Vascular territory (ACA or PCA vs. other) 12 (25.5) 57 (15.2) .072
Stroke mechanism
Large artery atherosclerosis 11 (23.4) 74 (19.8) .438
Cardiac embolism 6 (12.8) 76 (20.3)
Lacunar 21 (44.7) 135 (36.1)
Unknown0other cause 9 (19.1) 89 (23.8)
Barthel Index (# 80) 17 (37.0) 89 (23.9) .055
Dementia 23 (50.0) 76 (20.5) ,.001
Note. Figures are frequencies and within-group percentages. Significance
levels are based on chi-square analyses. Some within-group percentages
are based on an incomplete sample due to small amounts of missing data.
ACA 5 anterior cerebral artery; PCA 5 posterior cerebral artery.
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score greater than our cut-off for depression, 6 patients
(16.2%) remained depressed at all subsequent assessments,
3 patients (8.1%) were again found to be depressed at a
subsequent assessment but not at their final assessment, 5
patients (13.5%) were not depressed at a subsequent assess-
ment but were depressed at their final assessment, and 3
patients (8.1%) exhibited an erratic course. Regarding the
clinical course of the 374 patients who did not meet criteria
for depression 3 months after stroke, 299 of those 374 pa-
tients (80.0%) were evaluated at least once following that
baseline assessment. Thirty-seven of those 299 patients
(12.4%) met criteria for depression at least once during
long-term follow-up, while 262 of those patients (87.6%)
never met criteria for depression.
SIGH–D Item Endorsement by Stroke and
Dementia Status
We compared the stroke and control cohorts with regard
to the frequencies of endorsement of each of the items on
the SIGH–D during the assessment that was performed 3
months after stroke. Chi-square analyses suggested that
stroke status was associated with positive responses to the
SIGH–D items referring to depressed mood, anergia, de-
creased appetite, weight loss, suicidal ideation, somatic
complaints possibly associated with anxiety, hypochondri-
asis, and psychomotor retardation. Logistic regression de-
termined that stroke status was independently associated
with anergia (OR: 1.70; CI: 1.20–2.42), weight loss (OR:
1.82; CI: 1.05–3.17), hypochondriasis (OR: 1.82; CI: 1.25–
2.64), and psychomotor retardation (OR: 3.20; CI:
1.40–7.34).
Three months after stroke, demented patients differed
from nondemented patients with regard to SIGH–D total
score (6.8 6 5.7 vs. 4.3 6 4.3, p , .001 by t test), the
frequency of depression defined as a total score over 11
(23.2% vs. 7.3%, p , .001 by chi-square), and the fre-
quency of depression defined as a total score over 11 and
the spontaneous acknowledgment of depressed mood (15.2%
vs. 4.7%, p , .001 by chi-square). Regarding dementia
subtypes, patients with vascular dementia did not differ
significantly from patients with Alzheimer’s disease with
concomitant stroke with regard to SIGH–D total score or
the frequencies of depression recognized using our two
paradigms.
We compared the demented and nondemented stroke pa-
tients with regard to the frequencies of endorsement of each
of the items on the SIGH–D. Chi-square analyses suggested
that dementia status was associated with positive responses
to the SIGH–D items referring to depressed mood, de-
creased participation in work and activities, decreased ap-
petite, weight loss, early and late insomnia, suicidal ideation,
feelings of tension and irritability, hypochondriasis, lack of
insight, and psychomotor retardation. Logistic regression
determined that dementia status was independently associ-
ated with decreased participation in work and activities (OR:
2.08; CI: 1.04– 4.15), weight loss (OR: 1.66; CI: .91–3.00),
late insomnia (OR: 2.20; CI: 1.21– 4.00), and psychomotor
retardation (OR: 2.07; CI: 1.02– 4.18).
DISCUSSION
We identified depression in 11.2% of our cohort 3 months
after ischemic stroke. When depression was present in our
stroke cohort, it tended to be mild, and in most cases it
remitted in annual follow-up examinations. Depression was
associated with a major hemispheral stroke syndrome, re-
flecting the severity of neurologic impairment; infarcts in
the ACA and PCA territories, which supply limbic struc-
tures; dementia; and female sex. Interestingly, we found
that the odds ratios for those first two variables were higher
while the odds ratio for dementia was lower in a multivar-
iate model of the determinants of depression identified using
our more restrictive paradigm, suggesting that more severe
strokes involving limbic structures are associated with de-
pressed mood. When stroke patients were compared with
stroke-free control subjects and demented stroke patients
with nondemented stroke patients in the full cohort, how-
ever, the SIGH–D items that were most discriminating were
those that referred to somatic symptoms, while depressed
mood was not related to either stroke status or dementia
status.
Most prior studies have reported higher frequencies of
post-stroke depression than our own, but those higher fre-
quencies were themselves quite variable, as were the deter-
minants that have been identified (Gordon & Hibbard, 1997).
The studies of Robinson and his colleagues have been par-
ticularly influential. In one early study (Robinson et al.
1983), for example, they found that 27% of a sample of 103
stroke patients had major depression and 20% had dysthy-
mic disorder using DSM–III criteria. Based on studies fo-
cusing primarily on patients with hemispheral involvement,
Robinson and his colleagues have suggested that the loca-
tion of the presenting lesion is an important determinant of
the frequency and severity of post-stroke depression, with
anterior lesions involving the left hemisphere placing pa-
tients at greatest risk (Robinson et al., 1983, 1984; Stark-
stein et al., 1987). Among patients with right hemisphere
stroke, they have found that posterior lesions are associated
with post-stroke depression (Robinson et al., 1984; Stark-
stein et al., 1989). Despite the hypothesized importance of
lesion location in the etiology of post-stroke depression,
they have also reported that the symptom profiles of pa-
tients with post-stroke major depression and functional ma-
jor depression are similar (Lipsey et al., 1986).
In studies performed by other groups, Kotila et al. (1998)
diagnosed depression, defined as a Beck Depression Inven-
tory score over 9, in 47% of their cohort of patients 3 months
after first stroke; House et al. (1991) diagnosed major de-
pression or dysthymic disorder in 12% of their patients 1
month after first stroke and 8.5% of their control subjects
based on DSM–III criteria; and other groups have reported
intermediate frequencies of depression (Andersen et al.,
1994a; Burvill et al., 1995; Dennis et al., 2000; Ebrahim
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et al., 1987; Herrmann et al., 1998; Kim & Choi-Kwon,
2000; Pohjasvaara et al., 1998b; Wade et al., 1987). Al-
though certain studies have confirmed a relationship be-
tween anterior lesions of the left hemisphere and depression
(Åström et al., 1993; Sinyor et al., 1986a), most have not
(Andersen et al., 1995; Angeleri et al., 1997; Dam et al.,
1989; Gainotti et al., 1997a; Herrmann et al., 1998; House
et al., 1990; Schwartz et al., 1993). Carson et al. (2000)
performed a meta-analysis of 35 previous studies that had
investigated lesion location as a risk factor for depression.
They did not recognize a significant association between
those characteristics, noting that the relative risk of depres-
sion was 0.95 (CI: .83–1.10) for a left hemisphere versus a
right hemisphere lesion location and 1.17 (CI: .87–1.62) for
a left anterior hemispheral lesion location versus all other
hemispheral lesion locations. In our own study, we found
that infarcts in the ACA and PCA territories were associated
with an increased frequency of depression, consistent with
the report of Grasso et al. (1994) on the remote effects of
subcortical lesions on limbic structures, but hemispheric
laterality and a frontal lesion location were not relevant.
Alternatively, prior studies have recognized the importance
of factors such as a premorbid history of affective illness
(Andersen et al., 1995; Herrmann et al., 1998; Ng et al.,
1995; Pohjasvaara et al., 1998b; Schwartz et al., 1993),
post-stroke functional disability (Burvill et al., 1997; Den-
nis et al., 2000; Ebrahim et al., 1987; Herrmann et al., 1998;
Ng et al., 1995; Pohjasvaara et al., 1998b; Sato et al., 1999;
Schwartz et al., 1993; Sinyor et al., 1986b; van de Weg
et al., 1999; Wade et al., 1987), and a lack of social support
(Andersen et al., 1995; Åström et al., 1993; Burvill et al.,
1997) as determinants of depression after stroke.
It has been suggested that post-stroke depression is a
categorical rather than a continuous construct, with distin-
guishable determinants of its major and minor forms (Mor-
ris et al., 1994; Paradiso & Robinson, 1999). In contrast,
the unimodal rather than bimodal shape of the graph of total
scores on the SIGH–D in our stroke cohort shown in the
Figure and the results of a number of prior studies suggest
that post-stroke depression is a matter of degree rather than
kind. That is, both major and minor post-stroke depression
appear to be primarily due to psychological reactions to the
consequences of stroke (Gainotti et al., 1997b, 1999), par-
ticularly functional disability (Burvill et al., 1997; Dennis
et al., 2000; Ebrahim et al., 1987; Herrmann et al., 1998;
Ng et al., 1995; Pohjasvaara et al., 1998b; Sato et al., 1999;
Schwartz et al., 1993; Sinyor et al., 1986b; van de Weg
et al., 1999; Wade et al., 1987), or endogenous factors such
as a premorbid history of affective illness (Andersen et al.,
1995; Herrmann et al., 1998; Ng et al., 1995; Pohjasvaara
et al., 1998b; Schwartz et al., 1993), while the relevance of
characteristics such as lesion location is less clear. The fre-
quency of depression that we recognized in our stroke co-
hort is one of the lowest that has been reported, and, as
suggested by the results of certain studies cited above, we
propose that our findings were influenced primarily by the
relatively low frequency of premorbid psychiatric illness
that was present in our cohort. A premorbid history of de-
pression was reported in 22% of the patients of Andersen
et al. (1994a) and 19% of the patients of Pohjasvaara et al.
(1998b), for example, but only 5.7% of our stroke cohort
had a premorbid history of any significant psychiatric ill-
ness. A psychiatric history was more common among pa-
tients with than without depression in our study (i.e., 8.5%
vs. 5.4%), but that difference was not statistically signifi-
cant due to the underrepresentation of that characteristic
and a lack of statistical power.
Although the frequency of depression that we reported
was relatively low, the true frequency of depression in our
cohort may have been even lower due to incorrect classifi-
cations of depression resulting from the high frequency of
somatic complaints related to stroke and0or dementia but
not depression. Specifically, when we applied our alterna-
tive paradigm, in which we additionally required the spon-
taneous acknowledgment of depressed mood, the frequency
of depression in our stroke cohort dropped from 11.2% to
7.4%. Robinson and his colleagues have suggested that so-
matic symptoms are not more common among stroke pa-
tients unless depressed mood is also present (Fedoroff et al.,
1991; Paradiso et al., 1997), but our findings suggest that
clinicians should be sensitive to the similarities between
the somatic features that are commonly seen in older med-
ical patients and the clinical features that are convention-
ally accepted to be typical in depression (Linden et al.,
1995) and rely more on nonsomatic than somatic symptoms
in order to derive the most accurate diagnoses (Stein et al.,
1996).
Our study has certain limitations. First, our study was
performed at a tertiary care center, and most of our patients
were admitted to a dedicated stroke unit and treated by
neurologists specializing in stroke. It is likely that those
factors contributed to better neurologic outcomes and a re-
duced frequency of depression. Second, we could have per-
formed our baseline assessments in the acute phase following
stroke, which might have resulted in a higher estimate of
the frequency of depression, but we performed those assess-
ments 3 months after stroke in order to examine patients in
a more stable state following the period of maximal recov-
ery. We did note that 21 of the 374 patients who did not
meet criteria for depression 3 months after stroke (5.6%)
were taking anti-depressant medications, however, suggest-
ing that some of those patients might have met criteria for
depression if we had assessed them before that treatment
was initiated. Similarly, in certain cases, rehabilitation pro-
grams may have enhanced physical recovery and thus mood
during the first 3 months after stroke, suggesting that ear-
lier assessments could have identified additional cases of
depression prior to that intervention. Third, patients who
were not examined 3 months after stroke were more se-
verely impaired neurologically than patients who were ex-
amined, and the exclusion of those patients could have
resulted in an underestimation of the frequency of depres-
sion. In addition, patients who were not examined 3 months
after stroke were older and more often had a history of
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congestive heart failure than patients who were examined,
reducing our ability to identify associations between those
variables and depression. Fourth, the SIGH–D has certain
limitations as a screening instrument, including its focus on
symptomatology occurring during the preceding week, which
could result in the failure to identify cases of depression
that are fluctuating or that have recently begun to remit, and
its weighting toward somatic complaints, which could cause
the overestimation of the frequency of depression among
older, neurologically impaired patients. As reviewed in de-
tail in another publication (Desmond et al., 2000), it would
have been optimal for us to administer a clinical interview
such as the Structured Clinical Interview for DSM–IV Axis I
Disorders (First et al., 1997) for the diagnosis of depres-
sion, and alternative measures such as the Geriatric Depres-
sion Scale (Yesavage et al., 1983) are also available. Fifth,
we, like other groups, did not recognize an association be-
tween lesion location and depression, which may have re-
sulted in part from our failure to use quantitative brain
imaging measures in our analyses. We did note that vari-
ables representing lesion lateralization and frontal versus
nonfrontal lesion locations were not relevant, however, sug-
gesting that more precise measures should not have pro-
duced different results.
Finally, it is important to note that very few of our de-
pressed patients were being treated for that disorder, con-
sistent with the findings of numerous previous studies
(Angeleri et al., 1997; Ebrahim et al., 1987; Robinson &
Price, 1982; Wade et al., 1987). Regardless of the absolute
frequency of depression after stroke, it is a treatable disor-
der that warrants intervention when recognized. The results
of the limited clinical trials that have been performed in
stroke samples suggest that pharmacologic treatment can
be effective (Rigler, 1999; Robinson, 1998).
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